vs
Side-by-side financial comparison of Atlanta Braves Holdings, Inc. (BATRA) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
Atlanta Braves Holdings, Inc. is the larger business by last-quarter revenue ($61.3M vs $57.3M, roughly 1.1× RHYTHM PHARMACEUTICALS, INC.). Atlanta Braves Holdings, Inc. runs the higher net margin — -67.6% vs -83.0%, a 15.4% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 17.6%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -52.5%).
Atlanta Braves Holdings, Inc. is a sports and entertainment holding company that owns and operates the Atlanta Braves MLB franchise. It also manages adjacent mixed-use real estate, live events, merchandise sales, and media operations, serving fans across the U.S. Southeast and global baseball audiences.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
BATRA vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.3M | $57.3M |
| Net Profit | $-41.4M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | -81.2% | -82.2% |
| Net Margin | -67.6% | -83.0% |
| Revenue YoY | 17.6% | 36.9% |
| Net Profit YoY | -116.7% | -9.6% |
| EPS (diluted) | $-0.64 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.3M | $57.3M | ||
| Q3 25 | $311.5M | $51.3M | ||
| Q2 25 | $312.4M | $48.5M | ||
| Q1 25 | $47.2M | $32.7M | ||
| Q4 24 | $52.1M | $41.8M | ||
| Q3 24 | $290.7M | $33.3M | ||
| Q2 24 | $282.9M | $29.1M | ||
| Q1 24 | — | $26.0M |
| Q4 25 | $-41.4M | $-47.5M | ||
| Q3 25 | $30.0M | $-52.9M | ||
| Q2 25 | $29.5M | $-46.6M | ||
| Q1 25 | $-41.4M | $-49.5M | ||
| Q4 24 | $-19.1M | $-43.3M | ||
| Q3 24 | $10.0M | $-43.6M | ||
| Q2 24 | $29.1M | $-32.3M | ||
| Q1 24 | — | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | -81.2% | -82.2% | ||
| Q3 25 | 12.5% | -102.6% | ||
| Q2 25 | 13.4% | -93.4% | ||
| Q1 25 | -94.2% | -143.7% | ||
| Q4 24 | -35.8% | -98.6% | ||
| Q3 24 | 2.2% | -132.0% | ||
| Q2 24 | 8.8% | -139.2% | ||
| Q1 24 | — | -538.7% |
| Q4 25 | -67.6% | -83.0% | ||
| Q3 25 | 9.6% | -103.1% | ||
| Q2 25 | 9.4% | -96.1% | ||
| Q1 25 | -87.7% | -151.4% | ||
| Q4 24 | -36.7% | -103.6% | ||
| Q3 24 | 3.4% | -131.2% | ||
| Q2 24 | 10.3% | -110.9% | ||
| Q1 24 | — | -544.4% |
| Q4 25 | $-0.64 | $-0.73 | ||
| Q3 25 | $0.47 | $-0.82 | ||
| Q2 25 | $0.46 | $-0.75 | ||
| Q1 25 | $-0.66 | $-0.81 | ||
| Q4 24 | $-0.29 | $-0.71 | ||
| Q3 24 | $0.16 | $-0.73 | ||
| Q2 24 | $0.46 | $-0.55 | ||
| Q1 24 | — | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $99.9M | $388.9M |
| Total DebtLower is stronger | $738.6M | — |
| Stockholders' EquityBook value | $526.0M | $139.1M |
| Total Assets | $1.6B | $480.2M |
| Debt / EquityLower = less leverage | 1.40× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.9M | $388.9M | ||
| Q3 25 | $82.2M | $416.1M | ||
| Q2 25 | $96.2M | $291.0M | ||
| Q1 25 | $244.7M | $314.5M | ||
| Q4 24 | $110.1M | $320.6M | ||
| Q3 24 | $100.9M | $298.4M | ||
| Q2 24 | $121.2M | $319.1M | ||
| Q1 24 | — | $201.2M |
| Q4 25 | $738.6M | — | ||
| Q3 25 | $759.9M | — | ||
| Q2 25 | $703.1M | — | ||
| Q1 25 | $699.5M | — | ||
| Q4 24 | $617.1M | — | ||
| Q3 24 | $640.1M | — | ||
| Q2 24 | $600.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | $526.0M | $139.1M | ||
| Q3 25 | $560.3M | $148.8M | ||
| Q2 25 | $522.8M | $-11.9M | ||
| Q1 25 | $486.1M | $18.9M | ||
| Q4 24 | $524.2M | $21.7M | ||
| Q3 24 | $530.4M | $11.2M | ||
| Q2 24 | $512.7M | $39.3M | ||
| Q1 24 | — | $61.6M |
| Q4 25 | $1.6B | $480.2M | ||
| Q3 25 | $1.7B | $506.9M | ||
| Q2 25 | $1.7B | $372.7M | ||
| Q1 25 | $1.7B | $386.7M | ||
| Q4 24 | $1.5B | $392.3M | ||
| Q3 24 | $1.6B | $363.6M | ||
| Q2 24 | $1.6B | $381.8M | ||
| Q1 24 | — | $258.7M |
| Q4 25 | 1.40× | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 1.34× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 1.18× | — | ||
| Q3 24 | 1.21× | — | ||
| Q2 24 | 1.17× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.4M | $-25.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.4M | $-25.4M | ||
| Q3 25 | $-88.8M | $-26.6M | ||
| Q2 25 | $-8.1M | $-23.3M | ||
| Q1 25 | $95.8M | $-40.4M | ||
| Q4 24 | $28.9M | $-18.8M | ||
| Q3 24 | $-69.0M | $-25.2M | ||
| Q2 24 | $-34.3M | $-29.1M | ||
| Q1 24 | — | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-82.3M | — | ||
| Q1 25 | $76.3M | — | ||
| Q4 24 | $16.8M | — | ||
| Q3 24 | $-85.5M | — | ||
| Q2 24 | $-64.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -26.3% | — | ||
| Q1 25 | 161.5% | — | ||
| Q4 24 | 32.3% | — | ||
| Q3 24 | -29.4% | — | ||
| Q2 24 | -22.7% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 23.7% | — | ||
| Q1 25 | 41.3% | — | ||
| Q4 24 | 23.2% | — | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 10.5% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -2.96× | — | ||
| Q2 25 | -0.28× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.89× | — | ||
| Q2 24 | -1.18× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BATRA
| Baseball | $34.8M | 57% |
| Mixed Use Development Segment | $26.5M | 43% |
RYTM
Segment breakdown not available.
